TVM Capital Healthcare has built substantial expertise in investing growth capital in healthcare companies in fast growing markets. The firm‘s deal flow has been spread across many countries in the MENA Region and Southeast Asia, but in its first five deals it focused on the UAE, Qatar and Egypt, and is currently conducting growth and expansion programs for several companies across the region and into countries such as Saudi Arabia. Going forward the firm is broadening the geographical range of deals in Southeast Asia and has openend an office in Singapore. TVM Capital Healthcare will, however, always adhere to certain well established principles in guiding its selection process including:
1. practical considerations such as availability of a local TVM Capital Healthcare investment or operating team;
2. in countries where the firm is not directly represented, the presence of a strong, experienced local co-investor who it trusts; and
3. political and economic stability of the country it is investing in and a focus on currency risk mitigation.
Other than third party deal flow, the firm proactively builds on the historic strengths in the fields of long-term care, ventilated care, post-acute care, rehabilitation, home care, and fertility treatment for deals in countries outside of the determined growth strategy of the existing portfolio companies. As such, we selectively pursue projects in these subsectors in other regions, such as SEA, often in collaboration with trusted local investment partners or the network of highly experienced investment advisors and venture partners. Within the MENA Region, based on prior experience as well as the current political situation, the core target markets are expected to be the UAE, Saudi Arabia, Egypt. Deals will be driven by collaboration with local partners. Our main target markets in SEA are the main urban centers such as Singapore, Jakarta, Kuala Lumpur or Bangkok.